JP2019089805A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019089805A5 JP2019089805A5 JP2019016592A JP2019016592A JP2019089805A5 JP 2019089805 A5 JP2019089805 A5 JP 2019089805A5 JP 2019016592 A JP2019016592 A JP 2019016592A JP 2019016592 A JP2019016592 A JP 2019016592A JP 2019089805 A5 JP2019089805 A5 JP 2019089805A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amount
- composition according
- total weight
- iron oxyhydroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 21
- 239000000203 mixture Substances 0.000 claims 12
- CUPCBVUMRUSXIU-UHFFFAOYSA-N [Fe].OOO Chemical compound [Fe].OOO CUPCBVUMRUSXIU-UHFFFAOYSA-N 0.000 claims 10
- 229910021519 iron(III) oxide-hydroxide Inorganic materials 0.000 claims 10
- 229920002472 Starch Polymers 0.000 claims 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 6
- 229930006000 Sucrose Natural products 0.000 claims 6
- 239000008107 starch Substances 0.000 claims 6
- 235000019698 starch Nutrition 0.000 claims 6
- 239000005720 sucrose Substances 0.000 claims 6
- 230000009747 swallowing Effects 0.000 claims 5
- 239000000796 flavoring agent Substances 0.000 claims 4
- 239000003826 tablet Substances 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 2
- 239000007941 film coated tablet Substances 0.000 claims 2
- 235000019634 flavors Nutrition 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000003765 sweetening agent Substances 0.000 claims 2
- 238000009492 tablet coating Methods 0.000 claims 2
- 239000002700 tablet coating Substances 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 238000007907 direct compression Methods 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 238000007908 dry granulation Methods 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- -1 glidants Substances 0.000 claims 1
- 239000004021 humic acid Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229920003133 pregelled starch Polymers 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07120837.5 | 2007-11-16 | ||
| EP07120837 | 2007-11-16 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017016971A Division JP6538734B2 (ja) | 2007-11-16 | 2017-02-01 | 医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020153832A Division JP7216055B2 (ja) | 2007-11-16 | 2020-09-14 | 医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019089805A JP2019089805A (ja) | 2019-06-13 |
| JP2019089805A5 true JP2019089805A5 (OSRAM) | 2020-01-16 |
| JP6764959B2 JP6764959B2 (ja) | 2020-10-07 |
Family
ID=39535152
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010533575A Active JP5466164B2 (ja) | 2007-11-16 | 2008-11-13 | 医薬組成物 |
| JP2013257490A Active JP5961601B2 (ja) | 2007-11-16 | 2013-12-12 | 医薬組成物 |
| JP2015088748A Active JP6294260B2 (ja) | 2007-11-16 | 2015-04-23 | 医薬組成物 |
| JP2017016971A Active JP6538734B2 (ja) | 2007-11-16 | 2017-02-01 | 医薬組成物 |
| JP2019016592A Active JP6764959B2 (ja) | 2007-11-16 | 2019-02-01 | 医薬組成物 |
| JP2020153832A Active JP7216055B2 (ja) | 2007-11-16 | 2020-09-14 | 医薬組成物 |
| JP2022177769A Pending JP2023011873A (ja) | 2007-11-16 | 2022-11-07 | 医薬組成物 |
| JP2024186317A Pending JP2025013926A (ja) | 2007-11-16 | 2024-10-23 | 医薬組成物 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010533575A Active JP5466164B2 (ja) | 2007-11-16 | 2008-11-13 | 医薬組成物 |
| JP2013257490A Active JP5961601B2 (ja) | 2007-11-16 | 2013-12-12 | 医薬組成物 |
| JP2015088748A Active JP6294260B2 (ja) | 2007-11-16 | 2015-04-23 | 医薬組成物 |
| JP2017016971A Active JP6538734B2 (ja) | 2007-11-16 | 2017-02-01 | 医薬組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020153832A Active JP7216055B2 (ja) | 2007-11-16 | 2020-09-14 | 医薬組成物 |
| JP2022177769A Pending JP2023011873A (ja) | 2007-11-16 | 2022-11-07 | 医薬組成物 |
| JP2024186317A Pending JP2025013926A (ja) | 2007-11-16 | 2024-10-23 | 医薬組成物 |
Country Status (35)
| Country | Link |
|---|---|
| US (13) | US9561251B2 (OSRAM) |
| EP (6) | EP3492069B1 (OSRAM) |
| JP (8) | JP5466164B2 (OSRAM) |
| KR (2) | KR101438071B1 (OSRAM) |
| CN (7) | CN101861146A (OSRAM) |
| AR (1) | AR069312A1 (OSRAM) |
| AU (1) | AU2008322963B2 (OSRAM) |
| BR (1) | BRPI0820308B8 (OSRAM) |
| CA (1) | CA2700444C (OSRAM) |
| CO (1) | CO6280398A2 (OSRAM) |
| CY (3) | CY1118496T1 (OSRAM) |
| DK (4) | DK3143992T3 (OSRAM) |
| ES (5) | ES2908719T3 (OSRAM) |
| FI (1) | FI3895699T3 (OSRAM) |
| GT (1) | GT201000144A (OSRAM) |
| HK (1) | HK1207298A1 (OSRAM) |
| HR (4) | HRP20220318T1 (OSRAM) |
| HU (2) | HUE031293T2 (OSRAM) |
| IL (2) | IL205726A (OSRAM) |
| LT (3) | LT2222285T (OSRAM) |
| MA (1) | MA31898B1 (OSRAM) |
| MX (1) | MX2010005346A (OSRAM) |
| MY (2) | MY156383A (OSRAM) |
| NZ (1) | NZ585435A (OSRAM) |
| PH (1) | PH12015500727B1 (OSRAM) |
| PL (4) | PL3492069T3 (OSRAM) |
| PT (5) | PT3895699T (OSRAM) |
| RU (2) | RU2493831C3 (OSRAM) |
| SA (1) | SA112340044B1 (OSRAM) |
| SG (1) | SG188789A1 (OSRAM) |
| SI (4) | SI3895699T1 (OSRAM) |
| TN (1) | TN2010000152A1 (OSRAM) |
| TW (2) | TWI468167B (OSRAM) |
| WO (1) | WO2009062993A1 (OSRAM) |
| ZA (1) | ZA201004256B (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| BRPI0807212B1 (pt) | 2007-02-06 | 2022-01-11 | United Kingdom Research And Innovation | Processos para produzir um material sólido de íon metálico de poli oxo-hidróxi modificado por ligante, composições para uso em terapia que compreende o material sólido de íon metálico de poli oxohidróxi modificado por ligante e uso das composições e uso de uma composição compreendendo um material sólido de íon metálico de poli oxo-hidróxi modificado por ligante |
| TWI468167B (zh) * | 2007-11-16 | 2015-01-11 | 威佛（國際）股份有限公司 | 藥學組成物 |
| GB0814326D0 (en) * | 2008-08-05 | 2008-09-10 | Medical Res Council | Phosphate binding materials and their uses |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| AU2014218455B2 (en) * | 2009-07-21 | 2016-11-24 | Keryx Biopharmaceuticals, Inc. | Ferric Citrate Dosage Forms |
| CA2768656C (en) * | 2009-07-21 | 2016-10-04 | Keryx Biopharmaceuticals, Inc. | Ferric citrate dosage forms |
| HRP20240720T1 (hr) | 2013-11-27 | 2024-09-13 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Farmaceutski pripravak, koji sadrži čestice fosfatnog veziva |
| WO2015198304A1 (en) | 2014-06-22 | 2015-12-30 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| WO2016038541A1 (en) * | 2014-09-10 | 2016-03-17 | Lupin Limited | A manufacturing process for an iron containing adsorbent |
| JP5757493B1 (ja) * | 2014-09-24 | 2015-07-29 | 富田製薬株式会社 | 経口型鉄分補給用固形組成物及びその製造方法 |
| CN104688706B (zh) * | 2015-04-01 | 2017-07-14 | 成都欣捷高新技术开发有限公司 | 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法 |
| US10258647B2 (en) | 2015-09-01 | 2019-04-16 | Particle Dynamics International, Llc | Iron-polysaccharide complexes and methods for the preparation thereof |
| CN107397759A (zh) * | 2016-05-19 | 2017-11-28 | 欣凯医药化工中间体（上海）有限公司 | 基于铁的氢氧化物－降解的碳水化合物的磷结合剂、其制备方法及其应用 |
| EP3829761A1 (en) | 2018-07-30 | 2021-06-09 | Interquim S.A. | Process for preparing an adsorbent for phosphate in aqueous medium |
| US12171878B2 (en) | 2018-08-10 | 2024-12-24 | Kissei Pharmaceutical Co., Ltd. | Sucroferric oxyhydroxide-containing granules and pharmaceutical composition |
| RU2701738C1 (ru) * | 2018-10-22 | 2019-10-01 | Федеральное государственное бюджетное учреждение науки Институт химии нефти Сибирского отделения Российской академии наук (ИХН СО РАН) | Способ получения композита на основе соединений железа |
| SI3930686T1 (sl) | 2019-02-28 | 2023-11-30 | Renibus Therapeutics, Inc. | Novi železovi sestavki ter metode njihove izdelave in uporabe |
| US11090346B2 (en) * | 2019-05-28 | 2021-08-17 | Inbold Inc. | Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery |
| US20230049917A1 (en) * | 2019-12-27 | 2023-02-16 | Lupin Limited | Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof |
| WO2021137780A1 (en) * | 2019-12-30 | 2021-07-08 | İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Preparation of film tablet composition comprising heme iron for iron deficiency |
| EP4090318B1 (en) | 2020-01-16 | 2024-02-28 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Particles of a mixture of iron(iii)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide |
| EP3932535A1 (en) | 2020-07-01 | 2022-01-05 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid |
| CN113171353B (zh) * | 2021-04-25 | 2022-10-21 | 海南普利制药股份有限公司 | 一种马来酸曲美布汀片 |
| CN115155537B (zh) * | 2022-07-28 | 2023-05-09 | 安徽农业大学 | FeOOH功能化腈纶纤维及其制备方法和应用 |
| CN116196330B (zh) * | 2023-03-16 | 2024-09-20 | 广东赛康制药厂有限公司 | 一种治疗高磷酸血症药物的制备工艺 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2820740A (en) | 1953-02-27 | 1958-01-21 | Benger Lab Ltd | Therapeutic preparations of iron |
| CH397628A (de) | 1959-05-08 | 1965-08-31 | Hausmann Ag Labor | Verfahren zur Herstellung von therapeutisch verwendbaren Eisen-(III)-hydroxyd-Polymaltose-Komplexen |
| US3076798A (en) | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
| GB1200902A (en) * | 1967-05-13 | 1970-08-05 | Fisons Pharmaceuticals Ltd | Iron-dextran complexes |
| AT279048B (de) | 1967-07-04 | 1970-02-25 | Pharmazeutische Fabrik Montavit Gmbh | Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon |
| US3499837A (en) | 1967-11-20 | 1970-03-10 | Johns Manville | Waste water treatment phosphate removal by iron oxide |
| GB1249558A (en) | 1969-08-19 | 1971-10-13 | American Cyanamid Co | Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions |
| US3928581A (en) | 1972-09-13 | 1975-12-23 | Astra Laekemedel Ab | Certain polymer-iron complexes for treatment of iron deficiency |
| US4181718A (en) | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
| US4581141A (en) | 1978-02-27 | 1986-04-08 | Purdue Research Foundation | Dialysis material and method for removing uremic substances |
| US4327076A (en) | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
| CH650890A5 (de) | 1981-06-15 | 1985-08-15 | Edak Ag | Tragbares schutzgehaeuse fuer elektrische und elektronische geraete. |
| US4474859A (en) | 1982-02-05 | 1984-10-02 | Jujo Paper Co., Ltd. | Thermal dye-transfer type recording sheet |
| JPS5973576A (ja) * | 1982-09-16 | 1984-04-25 | グラクソ・グル−プ・リミテツド | ピペリジニルシクロペンタノ−ルヘプテン酸塩 |
| JPS5976535A (ja) | 1982-10-22 | 1984-05-01 | Kureha Chem Ind Co Ltd | 収着剤およびその製造法 |
| US4788281A (en) | 1984-01-04 | 1988-11-29 | Tosoni Anthony L | Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof |
| DE3422249A1 (de) | 1984-06-15 | 1985-12-19 | Pfeifer & Langen, 5000 Köln | Wasserloesliches eisendextran und verfahren zu seiner herstellung |
| US4668400A (en) | 1984-06-22 | 1987-05-26 | Veech Richard L | Hemodialysis processes and hemodialysis solutions |
| US5248492A (en) | 1986-07-03 | 1993-09-28 | Advanced Magnetics, Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| US4869828A (en) | 1988-02-26 | 1989-09-26 | Nalco Chemical Company | Stabilization of iron in aqueous systems |
| US4970079A (en) * | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
| US5213692A (en) | 1991-08-28 | 1993-05-25 | Kemiron, Inc. | Process for preparing preferred iron humates |
| TW271400B (OSRAM) * | 1992-07-30 | 1996-03-01 | Pfizer | |
| EP0582452B1 (en) * | 1992-08-04 | 1998-10-14 | Toda Kogyo Corp. | Granulated particles for magnetic particles for magnetic recording and process for producing the same |
| DE4239442C2 (de) * | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
| US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| US5624668A (en) | 1995-09-29 | 1997-04-29 | Luitpold Pharmaceuticals, Inc. | Iron dextran formulations |
| DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
| BR9813808A (pt) | 1997-12-19 | 2002-05-28 | Smithkline Beecham Corp | Processo para produção de comprimidos para dispersão na mordida |
| GB9802201D0 (en) * | 1998-02-03 | 1998-04-01 | Cerestar Holding Bv | Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules |
| UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| US6117451A (en) | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6156332A (en) | 1999-05-27 | 2000-12-05 | Ambi, Inc. | Method and composition for masking mineral taste |
| US6521247B1 (en) * | 1999-08-13 | 2003-02-18 | Warner Chilcott Laboratories Ireland Limited | Dual iron containing nutritional supplement |
| WO2001089484A2 (en) | 2000-05-22 | 2001-11-29 | Verion, Inc. | Method for increasing the compressibility of poorly binding powder materials |
| US6358526B1 (en) | 2000-08-16 | 2002-03-19 | Rexall Sundown | Method of making tablets and tablet compositions produced therefrom |
| US6576665B2 (en) | 2001-04-03 | 2003-06-10 | Braintree Laboratories, Inc. | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
| US6764997B2 (en) | 2001-10-18 | 2004-07-20 | Teva Pharmaceutical Industries Ltd. | Stabilized azithromycin compositions |
| US20030190355A1 (en) | 2002-04-05 | 2003-10-09 | Hermelin Marc S. | Modified release minerals |
| AR045068A1 (es) * | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
| MXPA06002257A (es) | 2003-08-26 | 2006-05-17 | Shire Holdings Ag | Farmaceutica que comprende compuestos de lantano. |
| US6903235B2 (en) | 2003-10-08 | 2005-06-07 | Panion & Bf Biotech Inc. | Pharmaceutical-grade ferric citrate |
| DE102004031181A1 (de) | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
| CN100345546C (zh) * | 2004-08-25 | 2007-10-31 | 浙江震元制药有限公司 | 氯诺昔康口腔速崩组合物及其制备方法 |
| CN1302772C (zh) * | 2005-05-24 | 2007-03-07 | 中国人民解放军第二军医大学 | 阿魏酸钠口腔崩解片及其制备方法 |
| EP1757299A1 (de) | 2005-08-25 | 2007-02-28 | Vifor (International) Ag | Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung |
| MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| US20080107787A1 (en) * | 2006-11-02 | 2008-05-08 | The Coca-Cola Company | Anti-Diabetic Composition with High-Potency Sweetener |
| EP1932807A1 (en) * | 2006-12-14 | 2008-06-18 | Novartis AG | Inorganic compounds |
| DK2319804T3 (en) | 2006-12-14 | 2015-01-19 | Novartis Ag | Iron (III) -carbohydrat-based phosphatadsorbens |
| SI2319804T1 (sl) | 2006-12-14 | 2015-01-30 | Novartis Ag | Fosfatni adsorbent na osnovi Ĺľelezo(III)-ogljikovega hidrata |
| TWI468167B (zh) | 2007-11-16 | 2015-01-11 | 威佛（國際）股份有限公司 | 藥學組成物 |
| AU2013203333B2 (en) | 2007-11-16 | 2015-04-02 | Vifor (International) Ag | Pharmaceutical compositions |
| GB0814326D0 (en) | 2008-08-05 | 2008-09-10 | Medical Res Council | Phosphate binding materials and their uses |
| HRP20240720T1 (hr) | 2013-11-27 | 2024-09-13 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Farmaceutski pripravak, koji sadrži čestice fosfatnog veziva |
-
2008
- 2008-11-06 TW TW097142829A patent/TWI468167B/zh active
- 2008-11-06 TW TW103118250A patent/TWI592159B/zh active
- 2008-11-13 SI SI200832210T patent/SI3895699T1/sl unknown
- 2008-11-13 PT PT211766969T patent/PT3895699T/pt unknown
- 2008-11-13 PT PT211767074T patent/PT3895700T/pt unknown
- 2008-11-13 EP EP18191458.1A patent/EP3492069B1/en active Active
- 2008-11-13 MY MYPI2010002266A patent/MY156383A/en unknown
- 2008-11-13 WO PCT/EP2008/065444 patent/WO2009062993A1/en not_active Ceased
- 2008-11-13 CN CN200880116176A patent/CN101861146A/zh active Pending
- 2008-11-13 SG SG2013011556A patent/SG188789A1/en unknown
- 2008-11-13 KR KR1020107013304A patent/KR101438071B1/ko active Active
- 2008-11-13 PL PL18191458T patent/PL3492069T3/pl unknown
- 2008-11-13 DK DK16195982.0T patent/DK3143992T3/en active
- 2008-11-13 PL PL08848615T patent/PL2222285T3/pl unknown
- 2008-11-13 CN CN202010986126.6A patent/CN112022822A/zh active Pending
- 2008-11-13 AU AU2008322963A patent/AU2008322963B2/en active Active
- 2008-11-13 SI SI200832030T patent/SI3143992T1/sl unknown
- 2008-11-13 HU HUE08848615A patent/HUE031293T2/en unknown
- 2008-11-13 LT LTEP08848615.4T patent/LT2222285T/lt unknown
- 2008-11-13 EP EP21176696.9A patent/EP3895699B1/en active Active
- 2008-11-13 ES ES18191458T patent/ES2908719T3/es active Active
- 2008-11-13 FI FIEP21176696.9T patent/FI3895699T3/fi active
- 2008-11-13 CN CN202010986348.8A patent/CN112022796A/zh active Pending
- 2008-11-13 HR HRP20220318TT patent/HRP20220318T1/hr unknown
- 2008-11-13 LT LTEP16195982.0T patent/LT3143992T/lt unknown
- 2008-11-13 AR ARP080104959A patent/AR069312A1/es not_active Application Discontinuation
- 2008-11-13 PT PT181914581T patent/PT3492069T/pt unknown
- 2008-11-13 NZ NZ585435A patent/NZ585435A/en unknown
- 2008-11-13 CN CN202010896640.0A patent/CN111789820A/zh active Pending
- 2008-11-13 HR HRP20170034TT patent/HRP20170034T1/hr unknown
- 2008-11-13 DK DK18191458.1T patent/DK3492069T3/da active
- 2008-11-13 HR HRP20230588TT patent/HRP20230588T3/hr unknown
- 2008-11-13 HU HUE16195982A patent/HUE041429T2/hu unknown
- 2008-11-13 PL PL16195982T patent/PL3143992T3/pl unknown
- 2008-11-13 JP JP2010533575A patent/JP5466164B2/ja active Active
- 2008-11-13 US US12/743,120 patent/US9561251B2/en active Active
- 2008-11-13 EP EP08848615.4A patent/EP2222285B1/en not_active Revoked
- 2008-11-13 EP EP21176707.4A patent/EP3895700B1/en active Active
- 2008-11-13 CN CN201510131417.6A patent/CN104688702A/zh active Pending
- 2008-11-13 BR BRPI0820308A patent/BRPI0820308B8/pt active IP Right Grant
- 2008-11-13 EP EP16195982.0A patent/EP3143992B1/en active Active
- 2008-11-13 MY MYPI2015001080A patent/MY193729A/en unknown
- 2008-11-13 SI SI200832190T patent/SI3492069T1/sl unknown
- 2008-11-13 ES ES21176696T patent/ES2950337T3/es active Active
- 2008-11-13 ES ES16195982T patent/ES2703158T3/es active Active
- 2008-11-13 KR KR1020137005435A patent/KR101590115B1/ko active Active
- 2008-11-13 MX MX2010005346A patent/MX2010005346A/es active IP Right Grant
- 2008-11-13 RU RU2010124424A patent/RU2493831C3/ru active Protection Beyond IP Right Term
- 2008-11-13 ES ES21176707T patent/ES2951457T3/es active Active
- 2008-11-13 DK DK21176696.9T patent/DK3895699T3/da active
- 2008-11-13 LT LTEP18191458.1T patent/LT3492069T/lt unknown
- 2008-11-13 ES ES08848615.4T patent/ES2612331T3/es active Active
- 2008-11-13 PT PT88486154T patent/PT2222285T/pt unknown
- 2008-11-13 PT PT16195982T patent/PT3143992T/pt unknown
- 2008-11-13 CN CN201611234717.8A patent/CN106619710A/zh active Pending
- 2008-11-13 CN CN202010986012.1A patent/CN112022821A/zh active Pending
- 2008-11-13 EP EP21176683.7A patent/EP3895698B1/en active Active
- 2008-11-13 DK DK08848615.4T patent/DK2222285T3/en active
- 2008-11-13 CA CA2700444A patent/CA2700444C/en active Active
- 2008-11-13 PL PL21176696.9T patent/PL3895699T3/pl unknown
- 2008-11-13 SI SI200831757A patent/SI2222285T1/sl unknown
- 2008-11-15 SA SA112340044A patent/SA112340044B1/ar unknown
-
2010
- 2010-04-08 TN TN2010000152A patent/TN2010000152A1/fr unknown
- 2010-05-13 IL IL205726A patent/IL205726A/en active IP Right Grant
- 2010-05-14 GT GT201000144A patent/GT201000144A/es unknown
- 2010-05-14 CO CO10058238A patent/CO6280398A2/es not_active Application Discontinuation
- 2010-06-03 MA MA32888A patent/MA31898B1/fr unknown
- 2010-06-15 ZA ZA2010/04256A patent/ZA201004256B/en unknown
-
2013
- 2013-06-20 RU RU2013128356A patent/RU2648760C3/ru active Protection Beyond IP Right Term
- 2013-12-12 JP JP2013257490A patent/JP5961601B2/ja active Active
-
2015
- 2015-03-31 PH PH12015500727A patent/PH12015500727B1/en unknown
- 2015-04-23 JP JP2015088748A patent/JP6294260B2/ja active Active
- 2015-08-18 HK HK15107932.9A patent/HK1207298A1/xx unknown
-
2016
- 2016-09-11 IL IL247741A patent/IL247741B/en active IP Right Grant
- 2016-12-23 US US15/389,549 patent/US10780113B2/en active Active
-
2017
- 2017-01-24 CY CY20171100099T patent/CY1118496T1/el unknown
- 2017-02-01 JP JP2017016971A patent/JP6538734B2/ja active Active
-
2018
- 2018-10-25 US US16/170,650 patent/US10682376B2/en active Active
- 2018-11-06 HR HRP20181837TT patent/HRP20181837T1/hr unknown
- 2018-11-27 US US16/200,943 patent/US10695367B2/en active Active
- 2018-12-19 CY CY20181101376T patent/CY1121230T1/el unknown
-
2019
- 2019-02-01 JP JP2019016592A patent/JP6764959B2/ja active Active
-
2020
- 2020-06-19 US US16/906,584 patent/US10925896B2/en active Active
- 2020-06-19 US US16/906,648 patent/US10925897B2/en active Active
- 2020-07-17 US US16/932,124 patent/US10933090B2/en active Active
- 2020-09-14 JP JP2020153832A patent/JP7216055B2/ja active Active
-
2021
- 2021-01-15 US US17/151,064 patent/US11013762B1/en active Active
- 2021-01-15 US US17/150,529 patent/US11013761B1/en active Active
- 2021-04-22 US US17/302,065 patent/US20220072035A1/en not_active Abandoned
- 2021-12-16 US US17/644,637 patent/US20220105130A1/en not_active Abandoned
- 2021-12-16 US US17/644,643 patent/US20220105131A1/en not_active Abandoned
- 2021-12-16 US US17/644,632 patent/US20220105129A1/en not_active Abandoned
-
2022
- 2022-03-21 CY CY20221100224T patent/CY1125300T1/el unknown
- 2022-11-07 JP JP2022177769A patent/JP2023011873A/ja active Pending
-
2024
- 2024-10-23 JP JP2024186317A patent/JP2025013926A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02359B (me) | Farmaceutska kompozicija koja sadrži derivate hinolina | |
| RU2013128356A (ru) | Фармацевтическая композиция, содержащая оксигидроксид железа, способ ее получения и применение | |
| CA2000763C (en) | Dispersable formulation | |
| US20150238426A1 (en) | Granular material for orally fast disintegrating tablets | |
| EP2468361B1 (en) | Vildagliptin Formulations | |
| JP2004518734A (ja) | カルベジロールの新規処方 | |
| IL273754B2 (en) | High-strength oral taxane compositions and methods | |
| JP4501024B2 (ja) | システイン類の苦味及び臭気が軽減された組成物 | |
| SE509694C2 (sv) | Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter | |
| KR20110068985A (ko) | 변형 방출 라미프릴 조성물 및 그것의 사용 | |
| EA030758B1 (ru) | Фармацевтические составы на основе вилдаглиптина | |
| JP2023052398A (ja) | ４－アミノ－３－ブタン酸類縁体含有固形製剤 | |
| CA2329046C (en) | Composition comprising l-ascorbic acid and pectin | |
| JP2017002092A5 (OSRAM) | ||
| JP2021028326A (ja) | レベチラセタムを含む錠剤 | |
| JP2013544272A5 (OSRAM) | ||
| CA2502582A1 (en) | Pharmaceutical formulation of olanzapine | |
| JP5718937B2 (ja) | パーキンソン病を治療するための医薬組成物及びその調製方法 | |
| JPWO2001089573A1 (ja) | 製剤の安定化方法 | |
| JP4221299B2 (ja) | フィルム錠剤製造用リバビリン顆粒 | |
| JP6965497B2 (ja) | レボセチリジン固形製剤 | |
| KR102647471B1 (ko) | 고미 및 이물감이 개선된 에르도스테인 과립제제 | |
| JP6176246B2 (ja) | 固形医薬錠剤およびその製造方法 | |
| WO2015198225A1 (en) | Oral pharmaceutical composition of tofacitinib | |
| JP2010516712A5 (OSRAM) |